drugset / Trial / NCT00215228

Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression

NCT00215228 ↗

Phase 2/3 Completed 26 enrolled Duke University Forest Laboratories · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

Low heart rate variability is a marker of increased risk of cardiac mortality, and is observed in depressed coronary artery disease patients. Some antidepressants may themselves, however, decrease heart rate variability. We will test the hypothesis that greater reduction in heart rate variability will be associated with duloxetine (which has noradrenergic activity) than escitalopram (a selective serotonin reuptake inhibitor). We will also test the hypothesis that changes in heart rate variability are related to the magnitude of norepinephrine transporter occupancy.

Timeline

Start
2005-07
Primary completion
—
Completion
2007-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Duloxetine Small molecule — —
Subject Escitalopram Small molecule — —